![Isabel Mestres: Join us as we turn plans into actions and bad news into hope.](https://oncodaily.com/pub/uploads/2023/09/Isabel-e1717744209383-1280x960.jpeg)
Isabel Mestres: Join us as we turn plans into actions and bad news into hope.
Isabel Mestres, CEO at City Cancer Challenge Foundation, recently shared on LinkedIn:
“Breast cancer affects us all deeply. In 2020, 2.3 million women faced this diagnosis, each representing a unique story. But these stories have a different ending depending on where you live.
In LMICs, late diagnoses make survival a distant hope, with rates varying from 66% in India to 40% in South Africa. On the other hand, in high-income countries the survival rates exceed 90%.
That’s where the World Health Organization’s Global Breast Cancer Initiative comes in, with an ambitious goal: to reduce breast cancer cases by 2.5% annually. Now a powerful collaboration between City Cancer Challenge and WHO is translating this vision into real action: we’ll use evidence-based approaches to health system strengthening to illustrate how countries can build capacity, increase access and empower women.
I’m grateful for the support received by AstraZeneca, Bristol Myers Squibb, Amgen, MSD and IFPMA, because cancer isn’t something one single actor can solve.
Join us as we turn plans into actions and bad news into hope. Together, we’re not just fighting breast cancer; we’re rewriting lives of entire families. ”
For the article click here.
Source: Isabel Mestres/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023